Emily Lilianne Newman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aggression | 7 | 2019 | 748 | 1.740 |
Why?
|
| Ethanol | 8 | 2022 | 1322 | 1.170 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 3 | 2022 | 88 | 0.960 |
Why?
|
| Receptors, GABA-A | 2 | 2016 | 621 | 0.770 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2017 | 894 | 0.700 |
Why?
|
| Social Behavior | 7 | 2024 | 1136 | 0.690 |
Why?
|
| Stress, Psychological | 8 | 2024 | 4487 | 0.680 |
Why?
|
| Behavior, Animal | 5 | 2024 | 1873 | 0.650 |
Why?
|
| Genes, fos | 1 | 2019 | 175 | 0.640 |
Why?
|
| Central Nervous System Depressants | 1 | 2017 | 164 | 0.540 |
Why?
|
| Alcohol-Related Disorders | 1 | 2017 | 238 | 0.490 |
Why?
|
| Aminopyridines | 1 | 2018 | 573 | 0.460 |
Why?
|
| Alcohol Drinking | 6 | 2022 | 4027 | 0.450 |
Why?
|
| Alcoholism | 2 | 2022 | 1973 | 0.450 |
Why?
|
| Midazolam | 1 | 2015 | 267 | 0.450 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2015 | 446 | 0.360 |
Why?
|
| Prefrontal Cortex | 3 | 2022 | 2219 | 0.360 |
Why?
|
| Self Administration | 2 | 2017 | 387 | 0.220 |
Why?
|
| Random Allocation | 2 | 2018 | 2393 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 22128 | 0.200 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2022 | 53 | 0.200 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2022 | 108 | 0.190 |
Why?
|
| Depressive Disorder, Major | 3 | 2024 | 4767 | 0.190 |
Why?
|
| Mice | 13 | 2024 | 81330 | 0.190 |
Why?
|
| Violence | 2 | 2019 | 935 | 0.180 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2021 | 359 | 0.170 |
Why?
|
| Neurosciences | 1 | 2024 | 369 | 0.170 |
Why?
|
| Animals | 18 | 2024 | 168089 | 0.160 |
Why?
|
| Genes, Immediate-Early | 1 | 2019 | 102 | 0.160 |
Why?
|
| Corticosterone | 1 | 2019 | 301 | 0.150 |
Why?
|
| Territoriality | 1 | 2017 | 6 | 0.150 |
Why?
|
| Brain | 4 | 2023 | 27094 | 0.140 |
Why?
|
| Quinine | 1 | 2016 | 51 | 0.140 |
Why?
|
| Sucrose | 1 | 2016 | 158 | 0.130 |
Why?
|
| Biogenic Monoamines | 1 | 2015 | 50 | 0.130 |
Why?
|
| Motor Activity | 2 | 2015 | 2712 | 0.110 |
Why?
|
| Histones | 1 | 2024 | 2570 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2549 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 10756 | 0.110 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 397 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 2893 | 0.100 |
Why?
|
| Fear | 2 | 2022 | 1477 | 0.090 |
Why?
|
| Point Mutation | 1 | 2016 | 1593 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 624 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2015 | 944 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1173 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2015 | 1134 | 0.080 |
Why?
|
| Male | 11 | 2024 | 360703 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2012 | 1417 | 0.070 |
Why?
|
| Female | 9 | 2024 | 392552 | 0.070 |
Why?
|
| Sex Factors | 1 | 2019 | 10553 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9520 | 0.050 |
Why?
|
| DNA, Circular | 1 | 2022 | 96 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 261 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 4569 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18222 | 0.040 |
Why?
|
| Serotonin | 1 | 2024 | 1042 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2022 | 371 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2022 | 537 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2022 | 999 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1129 | 0.030 |
Why?
|
| Reward | 1 | 2023 | 968 | 0.030 |
Why?
|
| Amygdala | 1 | 2022 | 1353 | 0.030 |
Why?
|
| Memantine | 1 | 2015 | 108 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 204 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 3788 | 0.020 |
Why?
|
| Humans | 7 | 2024 | 761222 | 0.020 |
Why?
|
| Motivation | 1 | 2019 | 2002 | 0.020 |
Why?
|
| Ketamine | 1 | 2015 | 517 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 11855 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20118 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10203 | 0.020 |
Why?
|
| Child | 2 | 2023 | 80154 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 221120 | 0.000 |
Why?
|